Revenue | ₹42.93Cr |
Net Profits | ₹8.54Cr |
Net Profit Margins | 19.89% |
Jenburkt Pharmaceuticals Ltd’s revenue jumped 7.24% since last year same period to ₹42.93Cr in the Q4 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 11.59% jump in its revenue since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit jumped 8.38% since last year same period to ₹8.54Cr in the Q4 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 31.18% jump in its net profits since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit margin jumped 1.05% since last year same period to 19.89% in the Q4 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 17.55% jumped in its net profit margins since last 3-months.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q4 results 2024 was ₹42.93Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q4 results 2024 was ₹8.54Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q4 results 2024 was 19.89%.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q4 results 2023 was ₹40.03Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q4 results 2023 was ₹7.88Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q4 results 2023 was 19.69%.